These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6194257)

  • 1. Pharmacological evidence for the existence of multiple functional pools of brain serotonin: analysis of brain perfusate from conscious rats.
    Kleven MS; Dwoskin LP; Sparber SB
    J Neurochem; 1983 Oct; 41(4):1143-9. PubMed ID: 6194257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action of LSD-25 on the serontoninergic system of the rat brain modified by administration of 5-hydroxytryptophan].
    Torre M; Bogetto F; Torre E
    Minerva Psichiatr; 1981; 22(3):163-4. PubMed ID: 6975868
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-Hydroxytryptophol and 5-hydroxyindoleacetic acid levels in rat brain: effects of various drugs affecting serotonergic transmitter mechanisms.
    Beck O; Lundman A; Jonsson G
    J Neural Transm; 1987; 69(3-4):287-98. PubMed ID: 2442302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Block by LSD of the increase in brain serotonin turnover induced by elevated ambient temperature.
    Aghajanian GK; Weiss BL
    Nature; 1968 Nov; 220(5169):795-6. PubMed ID: 5698754
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Effect of LSD on rat brain 5-hydroxy-tryptamine metabolism at elevated environmental temperature.
    Curzon G; Marsden CA
    Br J Pharmacol; 1976 Mar; 56(3):368P-369P. PubMed ID: 1260198
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain serotonin metabolism after tolerance dosage of LSD.
    Freedman DX; Boggan WO
    Adv Biochem Psychopharmacol; 1974; 10():151-7. PubMed ID: 4846536
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine.
    Rosecrans JA; Lovell RA; Freedman DX
    Biochem Pharmacol; 1967 Oct; 16(10):2011-21. PubMed ID: 6065966
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the concurrent behavioral and neurochemical effects of psychoactive drugs using the push-pull cannula.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1972 Jun; 181(3):387-98. PubMed ID: 5033008
    [No Abstract]   [Full Text] [Related]  

  • 10. Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Jan; 108(2):179-86. PubMed ID: 3156756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-(1-Naphthyl)piperazine, a central serotonin agonist.
    Fuller RW; Mason NR; Snoddy HD; Perry KW
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):37-45. PubMed ID: 2419952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro.
    Ziegler MG; Lovell RA; Freedman DX
    Biochem Pharmacol; 1973 Sep; 22(17):2183-93. PubMed ID: 4270151
    [No Abstract]   [Full Text] [Related]  

  • 13. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
    Jacoby JH; Poulakos JJ
    J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic lysergic acid diethylamide administration and serotonin turnover in various regions of the rat brain.
    Peters DA
    J Neurochem; 1974 Oct; 23(4):625-8. PubMed ID: 4430908
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
    Peters DA
    Biochem Pharmacol; 1974 Jan; 23(2):231-7. PubMed ID: 4149793
    [No Abstract]   [Full Text] [Related]  

  • 16. Vesicular and juxtavesicular serotonin: effects of lysergic acid diethylamide and reserpine.
    Halaris AE; Freedman DX
    J Pharmacol Exp Ther; 1977 Dec; 203(3):575-86. PubMed ID: 925959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function.
    Pettibone DJ; Pflueger AB
    J Neurochem; 1984 Jul; 43(1):83-90. PubMed ID: 6726257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence on 5-[3H]hydroxytryptamine binding site development in chick embryo by serotonergic compounds.
    Soblosky JS; Jeng I
    J Neurochem; 1985 Feb; 44(2):544-51. PubMed ID: 2578180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N,N-dimethyltryptamine and D-lysergic acid diethylamide on the release of 5-hydroxyindoles in rat forebrain.
    Randić M; Padjen A
    Nature; 1971 Apr; 230(5295):532-3. PubMed ID: 4927758
    [No Abstract]   [Full Text] [Related]  

  • 20. Action of serotoninmimetics in the behavioral despair test in rats.
    Górka Z; Wojtasik E; Kwiatek H; Maj J
    Commun Psychopharmacol; 1979; 3(3):133-6. PubMed ID: 315302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.